Clinical Trials Browser

Phase 1 × Precursor Cell Lymphoblastic Leukemia-Lymphoma × CTL019 chimeric antigen receptor × Clear all

NCT02529813 2022-06-30

CD19-Specific T-cells in Treating Patients With Advanced Lymphoid Malignancies

Phase 1 Completed

LymphoidOther hematologic neoplasm

Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Biphenotypic, Acute, Neoplasm, Residual, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT01551043 2020-07-09

Allo CART-19 Protocol

Phase 1 Terminated

LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT02810223 2016-10-14

Efficacy of CART-19 Cell Therapy in B Cell Acute Lymphoblastic Leukemia

Phase 1 Unknown

LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma